Metastatic (stage 4) breast cancer

Finding out you have metastatic breast cancer may be overwhelming and scary. Our breast cancer team is here to help you manage this ongoing disease. At Penn Medicine, we offer comprehensive care for metastatic breast cancer that includes advanced imaging, innovative treatments, and specialized support services through our Breast Cancer Program.

What is metastatic breast cancer?

Metastatic breast cancer, classified and referred to as stage IV breast cancer, is a late-stage form of breast cancer in which the cancerous cells have spread (metastasized) beyond the breast. All types of breast cancer begin in the breast tissue, but the breast cancer diagnosis becomes more serious once the cancer is no longer localized to one area (such as the breast). This happens when breast cancer cells travel through the bloodstream or lymphatic system.

Breast cancer most commonly spreads to the bones, lymph nodes, lungs, liver, and brain. In more than half of metastatic breast cancers, the cells spread to bones first. No matter where a metastatic tumor is found, it contains breast cancer cells and is considered breast cancer.

If breast cancer is not detected before it spreads, stage IV breast cancer may be your first diagnosis. In other cases, stage IV breast cancer may reoccur elsewhere in your body months or years after an initial diagnosis. About 30 percent of early-stage breast cancers return as metastatic disease.

Signs of metastatic breast cancer

Metastatic breast cancer symptoms depend on where the cancer is discovered. Common locations and symptoms include:

  • Bone: Symptoms can include a severe new bone pain that gradually becomes constant. Bone metastases can also cause fractures. 
  • Brain: Signs can include headaches, nausea, facial numbness, and changes in speech, vision, or balance. 
  • Liver: Liver metastases rarely produce symptoms. When they occur, symptoms can include pain in the right side of the abdomen, weakness, poor appetite, and yellowing of the eyes and skin. 
  • Lungs: Signs of lung metastases include lung pain, shortness of breath, and persistent cough.

Metastatic breast cancer diagnosis and staging

We use leading-edge breast imaging technology to understand the spread of breast cancer. Our specialized radiologists identify the location of the cancer, see how far it has spread, and determine how well your treatment is working. Imaging for metastasized breast cancer can include various options. 

Stage IV breast cancer prognosis

Metastatic breast cancer is always considered advanced stage IV breast cancer because it has spread (metastasized) to different organs or lymph nodes far from the breast. The most common areas of the body that cells may spread to are the brain, bones, liver, and lungs.

There is no known cure for metastatic breast cancer. Once cancer cells have spread to other areas of the body, it is not possible for them all to be removed. Therefore, your care team may choose to focus your treatment on shrinking tumors, slowing their growth, relieving symptoms, and improving your quality of life.

At Penn Medicine, our team of expert clinicians have access to industry-leading breast cancer research and clinical trials that continue to advance the treatment and outcomes of those diagnosed with metastatic breast cancer. Your care team will be able to guide you in treatment options based on your specific diagnosis.

Metastatic breast cancer treatment and management

We understand that metastatic breast cancer is a disease you will actively manage for the rest of your life. Our breast cancer treatment goal is to control the cancer and help you maintain a good quality of life.

Metastatic breast cancer treatment at Penn Medicine

Why choose Penn Medicine for stage 4 breast cancer?

We have the resources to identify metastatic breast cancer and get you the personalized treatment you need. At Penn Medicine, you can expect:

  • Advanced imaging: We use imaging studies such as CT scans, bone scans, and nuclear medicine tests to identify metastatic breast cancer. Imaging specialists across the Penn Medicine network collaborate to provide the most accurate interpretation of your scans. 
  • Access to innovative clinical trials: We offer breast cancer clinical trials for patients diagnosed with metastatic breast cancer. These studies give you access to new and promising treatment and imaging. 
  • Personalized treatment: We use tumor profiling to understand the genes in cancer cells. This information helps us individualize targeted therapies and treatment for your disease. 
  • Care close to home: We care for metastatic breast cancer at all our Penn Medicine breast cancer locations. Oncologists and radiologists throughout our network collaborate seamlessly to get you the treatment you need.
National Cancer Institute Designated Comprehensive Cancer Center badge on top of exterior shot of hospital

Rated “exceptional” by The National Cancer Institute

Penn Medicine’s Abramson Cancer Center is a world leader in cancer research, patient care, and education. Our status as a national leader in cancer care is reflected in our continuous designation as a Comprehensive Cancer Center by the National Cancer Institute (NCI) since 1973, one of 7 such centers in the United States. The ACC is also a member of the National Comprehensive Cancer Network, one of a select few cancer centers in the U.S., that are working to promote equitable access to high-quality, advanced cancer care.

Related specialties

Patient stories

Tool measures tumor growth for less uncertainty between scans

Neuroradiologists have developed the first-ever tool that gives a real-time assessment of an individual’s tumor, and relieves anxiety between scans.

Finding triple-negative breast cancer at 33, she chose ‘Team Penn’

Shocked to learn she had stage III breast cancer, Kate Korson knew just where to go. She flew home to Penn Medicine, where a clinical trial saved her life.

Patient puts national spotlight on cancer clinical trials

As Kate Korson recently shared on Good Morning America, both she and her mother participated in clinical trials at Abramson Cancer Center.

Redefining the cancer bell to celebrate with meaning

The Abramson Cancer Center wants to make bell-ringing more inclusive, so cancer patients can recognize their moments to cheer, large and small.

Jamil Rivers leads women of color to better breast cancer care

Jamil Rivers is a full-time working mom, living with metastatic breast cancer, and leading an initiative to help other women of color navigate cancer care.

A grateful patient pays it forward to treat uterine cancers

Dalia Jakas credits her doctor with curing her uterine cancer without harming her quality of life. Now, she’s paying it forward for future patients.

A cancer dietitian, a survivor herself, keeps patients moving

Breast cancer treatments can upend a fitness routine. Cancer dietitian Dorris Piccinin, a survivor herself, is inspiring patients to keep at it.

Volunteering for cancer research: an act of love

The Basser Center for BRCA is running an innovative cancer interception clinical trial that depends on volunteers with deep, personal ties to cancer.

Improving care for patients with acute lymphocytic leukemia

A clinical trial gave Becky Yu access to treatment that would become the new standard of care for newly diagnosed acute lymphocytic leukemia.

Faith, fate, and families

At the Basser Center for BRCA at Penn, a unique philanthropic investment is making rapid progress toward preventing and treating heritable cancer.

Schedule an appointment

We can help you schedule an appointment or you can search our directory of specialists.